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Abstract
The scientific questions we pursue are shaped by our cultural assumptions and biases, often in ways we are unaware. Here, we argue that 
modern biases against older adults (ageism) have unconsciously led aging biologists to assume that traits of older individuals are negative and 
those of younger individuals positive. We illustrate this bias with the example of how a medieval Chinese scholar might have approached the 
task of understanding aging biology. In particular, aging biologists have tended to emphasize functional declines during aging, rather than 
biological adaptation and population selection or composition processes; the reality is certainly that all these processes interact. Failure to 
make these distinctions could lead to interventions that improve superficial markers of aging while harming underlying health, particularly 
as the health priorities of older adults (autonomy, function, freedom from suffering, etc.) are often quite different from the goals of aging 
biologists (reducing disease, prolonging life). One approach to disentangling positive, negative, and neutral changes is to map trajectories of 
change across the life course of an individual (physiobiography). We emphasize that our goal is not to criticize our colleagues—we have been 
guilty too—but rather to help us all improve our science.
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Let’s conduct a thought experiment: You are a philosopher in Ming 
Dynasty China, a special advisor to the emperor to help him prolong his 
lifespan. You are an expert in both Confucian thought (hierarchy, ven-
eration of elders, etc.) as well as Taoist religion (living in harmony with 
nature, techniques to achieve immortality). Through an improbable 
time warp, you are able to travel to the future and learn about modern 
scientific methods and mechanisms, and then return to your own 
era and courtly functions. You come back fully equipped to conduct 
modern science in medieval China (including, through some magical 
mechanism, all the laboratories and trained personnel you would need), 
but you retain your cultural values. In your experience, most people do 
not live to become elderly, and those who do are exceptional, worthy 
of great respect. Their accumulated knowledge and opinions hold great 
weight, and everyone aspires to become like them.
What biological strategies might you try to prolong the 
emperor’s (and your) life? One approach would be to compare bio-
marker levels between younger and older subjects, with the hope of 
identifying biomarkers of aging. But unlike in modern research, you 
would not try to find ways to make old individuals have biological 
profiles resembling the young; rather, you would seek ways to make 
young individuals resemble the old, just as the young in your world 
seek to emulate the old psychosocially and culturally! Obviously, 
the elderly are worthy of emulation generally, and by copying their 
biomarker profiles, we could ensure that we are on the same trajec-
tory as they are, toward long life. We might also succeed in imbuing 
ourselves with some of their wisdom along the way.
As absurd as it is, this thought experiment clearly shows how 
the scientific questions we ask reflect our cultural biases, even 
when the science appears to be objective (eg, basic mechanisms of 
aging). When we use terms such as “immunosenescence” rather than 
“immunomodulation,” or even sometimes “age-related declines” ra-
ther than “age-related changes” (when the concept of decline reflects 
a judgment), we may be revealing our values and our and ageism (1), 
and allowing these biases to influence our science. For example, al-
gorithms to calculate biological age often use biomarkers thought 
to change monotonically with age to calculate a score, with the as-
sumption that lower values of biological age are preferable (2,3). 
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as the “norm” (4). In addition, research on heterochronic parabiosis in 
mice suggests that transfusions of blood from young to old mice have 
some rejuvenation properties (5), but epidemiological data suggest 
these benefits may not translate into humans (6). If it were that easy 
to prolong life and health, surely evolution would have found a way 
to keep any key factors elevated throughout life; most likely, declines 
in stem cell potential controlled by such factors protect against cancer, 
but at the cost of declining functionality. Yet we do not put the blood 
of old mice into young individuals and then tout its anti-cancer prop-
erties: the questions we ask, the experiments we conduct, and the way 
we interpret their results all reflect our cultural assumptions.
There is now substantial research showing that, as a society, we de-
value older adults and look at them as burdens to be minimized. In 
fact, older adults are one of the most stereotyped groups in our society 
(7), with focus on deficits, declines, and negative aspects of aging (8). 
Ageism is both widespread and frequent, with the vast majority of older 
Americans (84%) and Canadians (91%) reporting having experienced 
ageism (9). Is it any surprise then that our scientific framework supposes 
that the physiological states of the young are those to be emulated?
Obviously, our Chinese philosopher-sage is no more correct than 
we are. Both perspectives are arbitrary, and both miss the mark by 
letting cultural suppositions and biases color the science. The reality 
is that aging (by which we refer to all changes that are correlated or 
associated with chronological age (10)) is a composite of multiple 
processes. Some processes are pathological, reflecting problems in 
function. Some are adaptations to pathology as the internal physi-
ology adjusts to a new reality (11), likely a result of natural selection 
optimizing the life course given other age-associated changes (12). 
Some are selection biases, reflecting the fact that those who survive 
to be old are not a random sample of the population. And some are 
simply third factors that correlate with, but are not causally related to, 
any of the earlier. Even among the pathological processes, some might 
reflect an inherent, universal biological aging process, whereas others 
might reflect age-related changes in risk or population-dependent 
processes such as development of metabolic syndrome and diabetes.
Our cultural assumptions around aging have, in many cases, 
blinded us to these distinctions. Although we are hardly the first to 
remark on them, we believe that the role of ageism in structuring 
biological questions has so far passed largely unnoticed, and that 
by pointing it out we may be able to both improve our reasoning 
to understand aging biology, and to combat the poor treatment of 
older adults that results from these biases. For example, when older 
adults are asked what matters to them, their priorities (functionality, 
staying at home, absence of suffering, dying with dignity, proximity 
to loved ones) are often poorly aligned with those of aging biologists 
(curing diseases, prolonging life at all costs, etc.) (13,14).
One solution to this would be to use “physiobiography” to track 
individual physiological/biological trajectories over the life course, par-
allel to the recently proposed idea of immunobiography (15). In this 
way, we could identify trajectories of individuals with successful aging 
and seek to emulate these trajectories. Much as proposed by Freund 
(10) for phenotypic models of mouse aging, this approach minimizes 
the questions around definitions and judgments of aging, while at the 
same time explicitly forcing us to define what we consider “successful 
aging.” Along these lines, we also need to be careful to ensure that any 
“young” comparison groups are young adults rather than juveniles, as 
can often be the case in mouse studies; use of juveniles risks confounding 
aging and development. One approach to this would be develop more 
continuous methods in laboratory models; this has statistical benefits in 
addition to allowing nuance beyond the young-old dichotomy.
Although a physiobiography approach is promising, caution is still 
warranted: changing one or two elements in a trajectory could actually 
be detrimental if we do not know how to distinguish aspects of the 
trajectory that are causing problems from those that are adapting to 
them. Finally, it is always worth remembering the substantial body of 
evidence showing how important psychosocial, cultural, and lifestyle 
factors are in determining the aging process (16); the biology occurs in 
and is shaped by a larger context, from which it cannot be divorced.
Our goal here is not to politicize our field or make it politically 
correct. We cannot claim ourselves to be completely free from the 
ageism that is baked into modern society, and we make no judg-
ments. Rather, we argue strongly that becoming conscious of our 
cultural assumptions will not only help us to treat older adults 
better; it is also essential both for conducting good science and for 
directing this science toward the questions that can actually have the 
most benefit for our demographically changing society.
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